A Phase I/II, Two- Staged Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts and Clinical Recovery Successfully Completed

Trial Profile

A Phase I/II, Two- Staged Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts and Clinical Recovery Successfully Completed

Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Nov 2016

At a glance

  • Drugs Nowarta-110 (Primary)
  • Indications Warts
  • Focus Therapeutic Use
  • Sponsors Nowarta Biopharma
  • Most Recent Events

    • 09 Jul 2016 Primary endpoint has been changed from local adverse event and site reaction to Lesion Assessment and time frame of endpoint also changed from 7 days to 6 weeks,
    • 31 Mar 2016 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
    • 20 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top